BIONTTECH
Sensor Technology for explosive detection. Based on Georgia Tech Research.
Similar Organizations
S3I
S3I, LLC, is a technology leader specializing in biological threat detection. The company will be part of ICx BioSystems.
Founder
More informations about "BionTTech"
BioNTech - Wikipedia
BioNTech was founded in 2008 based on research by UÄŸur Åžahin, Özlem Türeci, and Christoph Huber, with a seed investment of €150 million from MIG Capital, a Munich-based venture capital firm, and AT Impf, an investment vehicle under control of the single family office of German billionaire twin brothers, Andreas and Thomas Strüngmann. The company's activities focus on the development and production of technologies and drugs for individualized cancer immunotherapy. …See details»
BioNTech | Our mission: basic research in mRNA …
BioNTech’s portfolio contains more than 25 product candidates in clinical trials. In pursuit of changing the treatment paradigm with individualized cancer therapies, our pipeline encompasses oncology product candidates including …See details»
From Discovery to Delivery – Meet our Senior Team - BioNTech
Having joined BioNTech in 2019, the year in which BioNTech went public, Lisa has since played a key role in building, expanding and professionalizing the finance organization. She has been …See details»
Management Report on the Group and the Company for the 2020 …
BNTX Combined Management Report 2022 - BioNTech
BioNTech SE is the parent company of the BioNTech Group and is responsible for the management and development of the Group. BioNTech SE has its registered office in Mainz, …See details»
Inside the hunt for a Covid-19 vaccine: how BioNTech …
Nov 13, 2020 By the time the World Health Organization declared a global pandemic in early March, the company had 20 mRNA candidates in development. Days later, it had signed deals with Pfizer and China’s ...See details»
BioNTech - Crunchbase Company Profile & Funding
BioNTech creates protein-based therapeutics, including antibodies and antibody-drug conjugates, to address various tumor types and bacterial infections. Small Molecule Immunomodulators BioNTech develops small molecules to enhance …See details»
Org Chart BioNTech - The Official Board
BioNTech has 47 executives and 3 subsidiaries. BioNTech. BioNTech IMFS; BioNTech US; InstaDeep; Please confirm your deletion . Delete or Cancel . Unfortunately, you don't own …See details»
The Road to a New Era of Immunotherapy - BioNTech
To date, the scientists behind BioNTech have optimized the structural components of mRNA (cap, the poly-A tail and its untranslated regions) to achieve increased intracellular stability of synthetic mRNA and translation, …See details»
BioNTech - The Org
BioNTech was founded in 2008 on the understanding that every cancer patient’s treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide. …See details»
BioNTech SE - Devex
Learn more about BioNTech SE's jobs, projects, latest news, contact information and geographical presence. BioNTech was founded in 2008 on the understanding that every …See details»
BioNTech Company Profile 2024: Stock Performance & Earnings
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious …See details»
BionTTech - Crunchbase Company Profile & Funding
Organization. BionTTech . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Sensor Technology for explosive detection. Based on Georgia Tech …See details»
BioNTech | The BioNTech Board
She was also responsible for building a new global oncology organization following a company-wide transformation. At Bristol-Myers Squibb Co., she held a pivotal role in evolving the …See details»
Background document on the mRNA vaccine BNT162b2 (Pfizer …
Jan 14, 2021 The Pfizer–BioNTech COVID-19 vaccine, BNT162b2, is an mRNA vaccine encoding a P2 mutant spike protein (PS 2) and formulated as an RNA–lipid nanoparticle of …See details»
Biontech Se ADR (BNTX-Q) Stock Price and News
Real-time Price Updates for Biontech Se ADR (BNTX-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
The BioNTech Approach: harnessing the natural power of immune …
We, at BioNTech, have a deep legacy of scientific innovation. As pioneers in the field of immunotherapies, we believe that science and innovation can make a difference for …See details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
BioNTech | The conception of our mRNA platforms
The architecture of our FixVac platform. Our FixVac (Fixed Vaccine) platform candidates consist of a fixed combination of mRNA-encoded non-mutated tumor antigens, which are known to …See details»